Gl. Alberts et al., Agonist-induced GTP gamma S-35 binding mediated by human 5-HT2C receptors expressed in human embryonic kidney 293 cells, EUR J PHARM, 383(3), 1999, pp. 311-319
The 5-HT2C receptor as heterologously expressed in various mammalian cells
mediates inositol 1,4,5-triphosphate (IP3) signal by activating G(q/11) sub
types of G proteins, but minimally promotes agonist-induced GTPy S binding
in membranes due to slow GTP turnover rates of the G proteins. Here we disc
overed robust (over 200%) agonist-induced GTP gamma(35)S binding mediated b
y the human receptor expressed in human embryonic kidney (HEK) 293 cells, a
nd investigated its pharmacology. Agonists concentration-dependently increa
sed GTP gamma(35)S binding in isolated membranes, which was competitively b
locked by antagonists. Intrinsic efficacies of agonists from GTP gamma(35)S
binding were comparable to those from IP3 measurement. Pertussis toxin tre
atment largely blocked serotonin-induced GTP gamma(35)S binding, serotonin
high affinity sites by 70% without altering the total binding sites, and re
duced IP3 release by 40%. GTP gamma(35)S-bound G alpha subunits from seroto
nin-activated membranes were mainly G(alpha)i, judging from immobilization
studies with various G alpha-specific antibodies. Inhibition of forskolin-s
timulated cAMP formation, however, was not observed. Apparently, the 5-HT2C
receptor-mediated GTP gamma(35) binding is a unique phenotype observed in
HEK293 cells, reflecting its coupling to pertussis toxin-sensitive G(i) sub
types, which contribute to the IP3 signal, along with pertussis toxin-insen
sitive G(q/11) subtypes. (C) 1999 Elsevier Science B.V. All rights reserved
.